Document is current
Any future updates will be listed below
-
Authors
Yu, Le
Deng, Yu https://orcid.org/0000-0002-3264-0809
Wang, Xiaodong
Santos, Charlene
Davis, Ian J.
Earp, H. Shelton
Liu, Pengda https://orcid.org/0000-0003-2755-3601
-
Funding
Funding for this research was provided by:
Gabrielle’s Angel Foundation for Cancer Research (Medical Research Award)
Andrew McDonough B+ Foundation Childhood Cancer Research Grant, the University of North Carolina at Chapel Hill University Cancer Research Fund
- License Information
-
More Information
Article History
Received: 14 September 2023
Accepted: 14 June 2024
First Online: 21 June 2024
Competing interests
: H.S.E. is a founder of Meryx (a UNC start-up) that is developing small molecule inhibitors for MERTK. H.S.E. and X.W. own stock in Meryx. The remaining authors declare no competing interests.
